Drawing for IRMA INTELLIGENT RISK MONITORING ASSESSMENT

USPTO serial 87480254

IRMA INTELLIGENT RISK MONITORING ASSESSMENT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
YOUNG, CARRIE SKYE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IRMA INTELLIGENT RISK MONITORING ASSESSMENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Devon E. White TMCP-UNC

DEVON E. WHITE TMCP-UNC UNC SCHOOL OF LAW102 RIDGE ROAD CB #3380CLINICAL PROGRAMSCHAPEL HILL, NC 27514

Goods and services

ClassDescriptionStatusFirst use
042Providing and hosting a secure electronic online system featuring technology for use in clinical trials that allows users to generate reports for real-time risk management, regulatory compliance analysis and risk trend analysis, performance risk scores, and risk mitigation and corrective action plans; Providing and hosting a secure electronic online system featuring technology for use in clinical trials that allows users to assess clinical trial site performance and to assess and study clinical trial site risks and to perform clinical trial site assessment scores and trend analysis; Consulting services in the field of clinical trial risk management software; Providing and hosting a secure electronic online system featuring technology that allows users to input data and to generate reports concerning quality assurance for clinical trial site, risk management and regulatory compliance, clinical trial site and clinical study team training and evaluation, in the clinical research, healthcare, insurance, human resources and entertainment and media fields; Software as a Service featuring non-downloadable computer software for use in clinical trials that allows users to generate reports for real-time risk management, regulatory compliance analysis and risk trend analysis, performance risk scores, and risk mitigation and corrective action plans; Software as a Service featuring computer software platforms for use in clinical trials that allows users to assess clinical trial site performance and to assess and study clinical trial site risks and to perform clinical trial site assessment scores and trend analysis; Software as a Service featuring non-downloadable computer software for use in featuring technology that allows users to input data and to generate reports concerning quality assurance for clinical trial site, risk management and regulatory compliance, clinical trial site and clinical study team training and evaluation, in the clinical research, healthcare, insurance, human resources and entertainment and media fieldsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 24, 2018MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 24, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 31, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 29, 2018EX1GSOU EXTENSION 1 GRANTED—
Mar 29, 2018EXT1SOU EXTENSION 1 FILED—
Mar 29, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 21, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 26, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 26, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 6, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 18, 2017ALIEASSIGNED TO LIE—
Aug 5, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 5, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Aug 5, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 5, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 5, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 28, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2017DOCKASSIGNED TO EXAMINER—
Jun 15, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 12, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance